Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track AWHL with free AI briefings, catalyst countdowns, and dilution alerts.
Start 7-day free trial → Log in

AWHL · Aspira Women's Health Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$477,000 Cash, Jun 2026
1mo Cash Runway (est.)
+31% Share Count, 1 Year
Follow AWHL by email Get an email when AWHL pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about AWHL, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

AWHL reported $477,000 in cash and short-term investments (as of Jun 30, 2026) and used about $1.2M/quarter in operations, an estimated runway of 1.2 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 79 · High

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when AWHL files for a raise →

Get the full AWHL picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for AWHL and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.